- UMS is positioned to benefit from a multi-year earnings upcycle, supported by SEMI’s projection of Wafer Fabrication Equipment (WFE) spending rising from USD 133 billion in 2026 to USD 172 billion by 2029.
- Margin expansion to 54% and Malaysia revenue growth of 91% confirm successful execution and the contribution of the Penang ramp.
- Revenue visibility is improving as customer capex converts into orders, with Lam Research emerging as a second growth engine alongside Applied Materials.
- Capex peaked at SGD 48.2 million in 2025, with working capital set to unwind and support free cash flow recovery and higher dividends.
- We derive a target price of SGD 2.35 based on a 20× P/E, implying 10% upside from the closing price on 24 April 2026.
Execution is driving margin expansion and growth stability
UMS Integration's 2025 results confirm that the transition from investment phase to earnings recovery is underway. The year marks a second consecutive year of earnings growth, demonstrating resilience despite a volatile operating backdrop. Net profit rose 2% to SGD 41.6 million, while revenue increased 4% to SGD 251.1 million despite tariff escalation, geopolitical uncertainty, and an uneven semiconductor equipment market in the first half.
Growth was led by the core semiconductor segment. Revenue from this segment rose 5% to SGD 214.7 million and now accounts for 86% of group revenue. This reinforces the company’s positioning within the wafer fabrication equipment supply chain.
Figure 1: UMS semiconductor segment revenue increased 5% in 2025
Margin expansion is the more important signal. Gross material margin increased 300 basis points to 54% in 2025 from 51% in 2024. This reflects a deliberate shift in product mix toward higher-value components.
Geographic data confirms that the Penang expansion is converting into revenue. Malaysia revenue rose 91% year on year to SGD 33.3 million, driven by the production ramp for the new customer. This suggests the transition from the investment phase to operating contribution and confirms the strategic role of the Penang facility within the group’s growth plan.
Figure 2: Malaysia now represents 13.3% of the group’s revenue
Improved earnings quality is now translating into capital returns. In November 2025, UMS announced a 1-for-4 bonus share issue, with shares credited on 15 January 2026, increasing the share count from 710.5 million to 888.2 million.
Dividend policy further reflects underlying cash flow strength. Total 2025 dividends amount to 5.0 Singapore cents per share on a pre-bonus basis. The board maintained the 2.0 cent final dividend despite the 25% increase in share count, resulting in a higher absolute payout.
AI-driven capex is extending the semiconductor cycle
UMS’s revenue tracks global wafer fabrication equipment spending with high sensitivity. When chipmakers invest in new fabs and advanced nodes, tool orders flow to its Original Equipment Manufacturer (OEM) customers, and component demand follows.
The current cycle is defined by scale and duration. SEMI characterises it as a structural “giga cycle” driven by AI demand, advanced node scaling, and rising semiconductor intensity across end markets. This suggests a sustained expansion rather than a cyclical recovery.
SEMI’s April 2026 300mm Fab Outlook supports that view. Equipment spending is projected to rise 18% to USD 133 billion in 2026 and a further 14% to USD 151 billion in 2027. Growth continues to USD 155 billion in 2028 and USD 172 billion in 2029. This four-year expansion extends revenue visibility beyond a typical order cycle.
Figure 3: Global sales of semiconductor manufacturing equipment spending is projected to climb for four consecutive years
Demand from leading chipmakers confirms both scale and duration. Taiwan Semiconductor Manufacturing Company (TSMC) raised 2026 revenue growth guidance to above 30% in USD terms and guided capex to the high end of USD 52 to 56 billion. This is supported by strong AI and high-performance computing (HPC) demand alongside tight supply. Samsung Electronics committed more than USD 73 billion to semiconductor capex and R&D in 2026, targeting advanced foundry and packaging. Micron Technology increased 2026 capex to USD 20 billion to expand high-bandwidth memory (HBM) capacity and accelerate installation timelines, while projecting the HBM market to grow from USD 35 billion in 2025 to around USD 100 billion by 2028.
The mechanism is consistent. AI demand tightens capacity, which pulls forward equipment orders and sustains utilisation. For UMS, this translates into durable component demand tied to both volume growth and technology transitions.
Order momentum is building across both key customers
Customer capex is now translating into tool orders, and UMS is directly in that flow.
Applied Materials (AMAT) guided 2Q FY2026 revenue of USD 7.65 billion and reiterated that its semiconductor equipment business will grow over 20% in calendar 2026, with demand weighted to the second half as customer cleanroom capacity comes online. UMS has renewed its integrated system contract with AMAT for three years, securing its position across existing product lines. A new product programme that entered production in 4Q2025 is contributing to revenue and is expected to add up to 20% of UMS’s AMAT revenue base as volumes normalise through 2026.
Lam Research is emerging as the more significant growth driver. The company reported 2Q FY2026 revenue of USD 5.34 billion and guided 3Q to USD 5.7 billion, alongside a USD 135 billion WFE outlook for 2026. Advanced packaging revenue is expected to grow more than 40% in the year.
Lam’s strength in electroplating and through-silicon via (TSV) etch positions it at the centre of HBM production. UMS supports these tool lines from its Penang facility, which is designed for high-precision, large-format components with significant entry barriers.
The geographic data confirms the ramp is real. Revenue from non-core markets rose 99% in 3Q 2025, driven by shipments to Lam’s Korea manufacturing hub, which supports key customers including Samsung Electronics and SK Hynix.
The new product introduction (NPI) pipeline extends this trajectory. UMS is qualifying multiple new products with Lam, with several expected to enter production in the near term. Each qualification adds a recurring revenue stream and increases switching costs. Once a component meets strict process and dimensional requirements, replacing a supplier requires a full qualification cycle. This dynamic reinforces customer stickiness and compounds revenue visibility over time.
Working capital is normalising, supporting dividend capacity
The Penang facility is moving from expansion to contribution, with capacity now translating into revenue.
Capex reached SGD 48.2 million in 2025, up from SGD 25.9 million in 2024, marking the peak of the investment phase as spending was front-loaded ahead of the production ramp. That ramp is now underway, with output beginning to convert into sales. Depreciation will continue to rise as the enlarged asset base is absorbed, which may weigh on reported earnings in the near term, but this is an accounting effect of prior investment, not weaker demand.
The shift is clearer in cash flow dynamics. Inventory increased by SGD 42.8 million in 2025 to support the ramp for Lam Research, positioning the group ahead of shipments. As deliveries accelerate through 2026, this inventory converts into revenue, releasing working capital and normalising operating cash flow. As result, the same investment that weighed on cash in 2025 begins to support cash generation and dividend capacity in the periods ahead.
Management has also signalled that higher dividends are under consideration. This introduces a second return driver alongside earnings growth, particularly for income-oriented investors.
Investment risks
Customer concentration remains the central risk, but the scope of the risk is declining.
Given AMAT’s historical role as UMS’s largest revenue contributor, any slowdown in its capital expenditure would have a direct impact on UMS’s order flow. This exposure is now partially offset by Lam Research, with Malaysia and Korea revenues forming a second operating base.
Execution risk sits within the NPI pipeline. Qualification delays or design changes can shift revenue recognition across periods. This risk is inherent to semiconductor manufacturing and tied to customer timelines rather than demand conditions.
Currency is a structural variable. Costs are largely MYR-denominated while revenue is USD-based. A weaker USD against MYR compresses margins at the SGD reporting level, as seen in 2025.
Structural change supports a higher valuation band
UMS trades at about 33× forward P/E, above its historical average, but this trend is also observed among other local semiconductor supply chain peers. The re-rating reflects two forces: a sectoral uplift driven by the structural giga cycle in semiconductor capex, and improved sentiment toward Singapore small and mid-cap companies (SMIDs) following market development initiatives.
Figure 4: Singapore semiconductor supply chain companies are trading above their historical P/E
The historical average of 13× is no longer an accurate representation. For most of the past decade, UMS derived roughly 80% of revenue from AMAT, with limited customer diversification. That concentration justified a persistent discount and capped valuations in the low-to-mid teens. The structure has since evolved. Lam Research is now established as a second major OEM customer, supported by an expanding NPI pipeline. Each successful qualification increases integration depth and improves revenue visibility, structurally reducing single-customer dependence.
Liquidity and market access have also improved. The Bursa secondary listing has broadened the investor base and reduced the illiquidity discount that historically constrained valuation. At the policy level, UMS also stands to benefit from Singapore’s Equity Market Development Programme (EQDP), which targets deeper liquidity and stronger institutional participation, especially for SMIDs.
The implication is a narrowing of the historical discount. We raise the fair P/E from 15x to 20x to reflect structural improvement without pricing in peak conditions. This remains below the current approximately 33× and below all monthly observations since July 2025. Applying 20× to 2028 forecasted EPS, we derive a target price of SGD 2.35, implying 10% upside from the closing price on 24 April 2026.
UMS (SGX: 558) remains a direct beneficiary of the semiconductor super cycle among SGX-listed names, now operating across a longer-duration cycle supported by a broader customer base and stronger cash flow generation. Improved visibility underpins a more durable growth profile, with potential for further upward revisions.
Table 1: Valuation table
|
|
2025 |
2026E |
2027E |
2028E |
|
EPS |
0.047 |
0.069 |
0.093 |
0.118 |
|
EPS growth |
2.6% |
47.7% |
34.8% |
26.0% |
|
PE Ratio |
24.3 |
30.9 |
22.9 |
18.2 |
|
Dividend |
4.4% |
2.5% |
2.6% |
2.9% |
|
Upside Potential (excluding dividend) |
10% |
|||
|
Target Price |
2.35 |
|||
|
Source: Bloomberg Finance L.P., iFAST Estimates Note: All EPS figures are presented on a post-bonus adjusted basis for comparability with the forward forecast period. |
||||
Figure 5: Share price vs. EPS
Declaration:
For specific disclosure, at the time of publication of this report, IFPL (via its connected and associated entities) and the analyst who produced this report hold a NIL position in the abovementioned securities.
This research report was prepared with the assistance of artificial intelligence (AI) tools. iFAST Financial Pte Ltd does not rely exclusively on AI for content generation; the content of this report – including all investment theses, ratings, price targets and conclusions – has been independently reviewed and verified by the research analyst(s) to ensure accuracy and professional integrity.
All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.
Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).
iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.